Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
68.69
-1.02 (-1.46%)
At close: Mar 18, 2026, 4:00 PM EDT
68.75
+0.06 (0.09%)
After-hours: Mar 18, 2026, 4:10 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $999.01 million as of March 18, 2026. Its market cap has increased by 408.19% in one year.
Market Cap
999.01M
Enterprise Value
952.83M
1-Year Change
408.19%
Ranking
Category
Stock Price
$68.69
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $999.01M, an increase of 403.95%. That is a compound annual growth rate of 145.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 1.01B | -11.76% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.08B |
| ArriVent BioPharma | 1.07B |
| Savara | 1.07B |
| Monte Rosa Therapeutics | 1.06B |
| Bicara Therapeutics | 1.06B |
| Pharming Group | 1.06B |
| Geron | 1.06B |
| Aktis Oncology | 1.04B |